Download person specification - consultant in clinical oncology

CONSULTANT IN CLINICAL ONCOLOGY
with an interest in the management of Colorectal and Breast cancer and
acute oncology
1.
Background Information
This is a new post, supported by the Greater Manchester and Cheshire Cancer
Network and The Christie NHS Trust.
Candidates must by law be on the General Medical Council Specialist Register in
Clinical Oncology or they must provide evidence that they will be on the register
by the time that they take up this appointment.
The purpose of the new post is to strengthen the clinical oncology service for
patients living in the Greater Manchester and Cheshire Network, with particular
emphasis on Colorectal Cancer and Breast cancer. In addition this post will
provide Acute Oncology input in Salford Foundation Hospital trust.
The successful applicant would become an active member of the Christie
Colorectal Cancer and Breast cancer disease groups, consisting of surgeons,
clinical oncologists and medical oncologists, pathologists, radiologists, nursing
and allied health professionals. The new consultant would be based at The
Christie, but would also work closely with the Colorectal Cancer and Breast
cancer team at Salford in terms of providing advice on radiotherapy/systemic
therapy.
2.
The Cancer Centre
The Christie and Holt Radium Institute moved to the present Withington site in
1932 and has grown to be the largest single site cancer hospital in the United
Kingdom. The Trust has been designated a separate teaching hospital of the
University of Manchester. Along with the Paterson Institute for Cancer Research
and North Western Regional Medical Physics Department, it formed The Christie
NHS Trust in 1991. The Christie became a Foundation Trust in 2007.
200 beds are in use at the Christie. The Department of Clinical Oncology beds
are sited in 4 wards which are organised on a site group basis. A medical
admissions unit was opened in December 2007 to improve access for clinical
emergencies and provide immediate clinical care of non elective admissions. The
1
remainder of the beds are used for chemotherapy, haematological oncology,
endocrinology and surgery.
There is an Adult Outpatient Department and separate facilities for minor surgical
procedures.
There is designated Outpatient chemotherapy suite which opened in November
2010 which will in addition to chemotherapy delivery houses a Phase I / II / III
research facility and a Private patient in patient suite.
Plans are in place for the development of a chemotherapy delivery unit in
Salford.
The Department of Clinical Oncology presently provides a service to Greater
Manchester and Cheshire, and parts of Lancashire, through regular clinics
(mainly weekly), staffed by its consultants (see appendix 1). The population of
the Christie’s catchment area is approximately 3.2 million. A total of 10,500 new
patients with cancer were seen by the Christie and associated clinics in 2008. In
2008, 7,500 patients were treated with radiotherapy. We have close links with
the Rosemere Cancer Centre at Preston.
The Radiotherapy Department has 10 service linear accelerators, a research linac
suite, and a Pantak superficial x-ray therapy unit. Three of the linacs are Elekta
Synergy linacs with facilities for image guide radiotherapy. There are 2
conventional simulators, one with cone beam imaging and 1 CT simulator. There
is an ADAC Pinnacle computerised treatment planning system. There is an active
IMRT programme with 30% of all patients treated with radical radiotherapy
receiving IMRT.
There is a dedicated linear accelerator for private patients which is operated in a
joint Venture with HCA.
A Satellite Radiotherapy facility opened in Oldham in March 2010 and a further
opened at Salford Royal NHS FT in July 2011.
The Salford satellite radiotherapy facility has 2 state-of-the-art Varian Novalis
Linear accelerators. This is the first UK site with a pair of these exciting, recently
developed machines, which offer full capacity for intra-cranial and extra-cranial
stereotactic radiosurgery, on-treatment imaging with cone-beam CT and EXACTTRAK and rapid-arc IMRT. The centre also has a CT-simulator and fully-equipped
mould room. The opening of the centre will bring a stereotactic radiosurgery
service to Greater Manchester for the first time, and the centre will also deliver
radiotherapy for the common cancers (GU, breast, lung, GI) to patients from the
North West Sector (Wigan, Bolton, Salford) and for CNS patients requiring
2
conventional radiotherapy treatments of greater complexity or who live in the
North West or North East (Pennine Acute) sectors.
At the Christie central site there is a purpose built, dedicated Radiotherapy
Theatre with an active Brachytherapy service There is a high dose rate
microselectron unit and a Pulsed dose rate Brachytherapy system. Facilities are
present for interstitial therapy (including prostate brachytherapy) and manually
afterloaded brachytherapy. In 2010 approximately 200 permanent Iodine 125
seed implants were conducted. HDR brachytherapy is now in place for prostate
patients.
There is a fully equipped Mould Room.
The Isotope Department provides facilities for the therapeutic use of I 131, P 32,
Sr 89 and Samarium. There are three rooms for the management of patients
being treated with unsealed Isotopes.
A dedicated Brachytherapy and radionuclide facility will be opened in 2012.
The Christie has dedicated Histopathology, Haematology, Biochemistry and
Diagnostic Radiology Departments. In addition to standard radiological and
radionuclide imaging facilities the Radiology Department has three whole body
CT scanners, two MRI scanners and CT - PET. The Radiotherapy Department
has access to CT scanning & MR scanning sessions for treatment planning
There is a large group of therapeutic radiographers. The Christie is a teaching
unit of the University of Liverpool School of Therapy Radiography.
A dedicated on-site medical physics group directed by Dr Ranald Mackay
supports the Radiotherapy Department and is active in implementing novel
technological developments in radiation technology.
There is an active Academic Radiation Oncology department led by Professor Tim
Illidge. In addition there are currently 3 research active Senior Lecturers.
The trust and the CRUK have built the Wolfson Molecular Imaging Centre with a
dedicated cyclotron, PET scanners and associated clinical and research facilities.
The Christie also has a University Department of Medical Oncology headed by Dr
Juan Vallle .There are 18 other Consultant grade appointments in Medical
Oncology.
The Department of Medical Oncology is actively involved in research and routine
clinical work and in joint collaborative programmes with the Department of
Clinical Oncology in the field of lymphomas, sarcomas, melanoma, leukaemia and
lung, breast, ovary, renal, testis and upper and lower GI cancer. Clinical
3
Oncology and Medical Oncology Consultants work closely together in site
specialised Disease Orientated Groups
The Christie also has clinical groups specialising in Palliative Medicine, Surgical
Oncology, Paediatric and Adolescent Oncology, Endocrinology, Psychological
Medicine and Clinical Genetics.
The Christie has a Statistics Department, which offers support to clinicians
involved in clinical studies and trials. The Trust has a specific intranet with IT
support
The Christie has dedicated facilities for Private patients. These facilities have
been advanced following the creation of a joint venture with HCA in September
2010. This has seen the development of new in patient wards, a dedicated
outpatient and chemotherapy facility and in September 2011 the opening of a
dedicated radiotherapy facility .
4
3
Details of the Post
It is envisaged that the post-holder would split their clinical commitments between
breast cancer and colorectal cancers and would take a leading role in the development
of an Acute Oncology service which the post holder would provide together with
established Consultant colleagues within other disease site groups to Salford Royal
Hospital NHS Foundation Trust. The post would be co located at Salford Royal Hospital
NHS Foundation Trust and the Christie Withington site.
a)
Breast Cancer
The post-holder would join the 10 existing Breast consultant Clinical Oncologists,
to support the expanding breast service. This service encompasses all of the
breast tumours diagnosed throughout the Greater Manchester and Cheshire
Cancer Network. This service is integrated with the Medical Oncology department
at the Christie hospital
The post-holder will provide a comprehensive breast cancer service to patients
from Salford Royal Hospital NHS Foundation Trust and will develop local
chemotherapy delivery and MDT support. The post-holder will join Dr Magee in
providing this service and initially will conduct a joint clinic at the Christie
alongside Dr Magee. The delivery of radiotherapy will for the majority of
patients take place in Salford. Initially chemotherapy will be delivered at the
Christie but in time this will transfer to Salford as the local facility is developed.
b)
Colorectal Cancer
The post holder would work alongside Dr Mark Saunders to provide a
comprehensive colorectal cancer service to patients from Salford Royal Hospital
NHS Foundation Trust and will develop local chemotherapy delivery. In addition
the post holder would hold a joint clinic at the Christie with the colorectal team
and work with colleagues to deliver the rectal radiotherapy service.
The GI non-surgical oncology group has an international reputation for clinical
trial activity. Chemo-radiotherapy protocols are being examined in clinical trials
and technical radiotherapy developments and image guided techniques are being
developed. The post holder would be expected to take an active role in research
and development, particularly in developing radiotherapy techniques for GI
cancer. The Clinical Oncology Group comprises Drs Saunders, McBain, Alam and
Misra. The Medical Oncology consultants that specialise in colorectal cancer are
Drs Valle, Wilson, Hasan, Mullamitha and Braun
The GI colorectal and hepatobiliary trials unit comprises at least 15 members of
staff. They include a trials coordinator, a grants / senior trials administrator, 7
research nurses, 6 data managers, a trials administrator, 2 nurse clinicians, a GI
5
research radiographer and a GI specialist nurse. All are dedicated to the
management of patients being treated as part of clinical trials. Presently we are
recruiting into about 20 clinical trials and we also have a similar number of
studies that are closed but have patients on follow-up. Trials include NCRN trials,
Pharmaceutical trials, biotec trials, Investigator Initiated Trials (IITs) and tumour
biomarker studies. In 2007 we screened approximately 25% of our patients and
entered 17% into clinical trials.
b)
Acute Oncology
Salford Royal Hospital NHS Foundation Trust in collaboration with the Christie are
planning to implement an Acute Oncology service. It is envisaged that this will
build upon the current service which provides site specialised support through
the disease groups both at the Christie and within Salford Royal Hospital NHS
Foundation Trust, together with the generic “Christie Hotline Clinic”. This post
holder will join a team of established consultants who are currently providing the
clinical aspects of this service. This post holder together with nursing support
will formalise this service to provide dedicated and comprehensive support. It is
expected that in addition to their other clinical roles they will contribute 2-3 PAs
of activity to this role.
c)
Clinical Staff in Clinical Oncology
The medical staff establishment provides for 32 Clinical Oncology Consultants,
(see appendix 1) including 3 academic consultants and eighteen Specialist
Registrars in Clinical Oncology. There is a junior doctor team at F2 and CMT
level, working jointly with medical oncology and haematology, within the Division
of Networked Services.
d)
Duties of Post
The appointee will be based at The Christie and Salford Royal Hospital NHS
Foundation Trust and will be a member of the Clinical Oncology consultant
group.
The post will involve the care of patients with Breast and colorectal as defined
above.
The post holder will be required to conduct outpatient clinics involving
chemotherapy delivery, radiotherapy planning sessions, to supervise patients
6
receiving radiotherapy and chemotherapy and to conduct ward rounds in a
manner providing optimum patient care and efficient use of the hospital’s
resources.
The initial allocation of sessions if the appointment is full time is expected to be:
SERVICE
Location
Programmed Activity
Direct Clinical Care
Out –patient Clinics, Christie
2
MDT meetings
Acute Oncology
0.5
2
Out-patient Clinics
Radiotherapy planning /
simulator / on treatment
reviews, The Christie / Salford
2
1
Supporting professional
Activities
2.5 (1 to support Acute Oncology)
(training, CPD, teaching, audit,
clinical
governance,research,
appraisal
and
clinical
management)
Total
10
This may be altered in response to the requirements of the Clinical Oncology
service in agreement with the Clinical Director of Clinical Oncology.
The agreed work plan will be subject to annual review in line with Trust policy.
This review will also include an assessment of professional development and
defined goals for the future. In the event of the consultant electing to work part
7
time a pro rata adjustment of fixed sessions would be anticipated. This will be
discussed and agreed with the Division.
The Department has evolved, over many years, a policy of mutual co-operation
between the consultants. The department consultant group meets monthly to
discuss joint management policies. Consultants are grouped in teams of two to
six supported by junior staff .The teams accept responsibility for agreed fields of
work and for cover for absence arrangements. All consultants are expected to
co-operate in these arrangements and to be involved in a number of clinical
areas of work.
A Clinical Director, Dr J Logue, chairs the department. The clinical oncology
department works with the departments of medical oncology, young oncology
and palliative care as part of the Network Services Division, with Jason Dawson
as General Manager.
All consultants in the department share in an on-call rota that involves a
commitment to a full week in every six months. This covers the Specialist
Registrar who is second on-call.
The appointee will have office accommodation and access to a secretarial
service.
d)
Administration
The appointee will be a member of the Department of Clinical Oncology
Consultant Group. The appointee will also be a member of The Christie Medical
Liaison and Advisory Group.
The Clinical Director within the consultant group negotiates administrative duties
within the Clinical Oncology Department and consultants are expected to accept
responsibility for at least one area. This responsibility is regularly reviewed and
can be altered following consultation and agreement with the Director and
colleagues.
The present Executive Directors of the Trust are: Caroline Shaw
Ian Moston
Dr Chris Harrison
Jackie Bird
Roger Spencer
Chief Executive
Executive Director of Finance & Performance
Medical Director
Executive Director of Nursing & Governance
Chief Operating Officer
The Trust board is chaired by Lord K Bradley
e)
Teaching
8
The Department of Clinical Oncology participates in the clinical undergraduate
teaching programme of the University of Manchester and students visit the
hospital for seminar, outpatients and bedside teaching at different stages in their
training. There are dedicated courses designed for postgraduate students
studying for the Part I and II examinations of the Fellowship of the Royal College
of Radiologists. Consultants are expected to participate in the specialist registrar
and F2 teaching programme.
Post-graduate training is co-ordinated by the clinical oncology specialty training
group. The Training Programme Director in Clinical Oncology is Dr Lip Lee
Undergraduate training is coordinated by Dr R A Cowan, Director of Education.
The hospital has a Medical Library staffed by professional librarians offering a
range of services including a modern journal collection, extensive book library
and on line search facilities.
g)
Research
Attached to The Christie is the University of Manchester Paterson Institute, an
extensive complex of laboratories supported by the Cancer Research UK
(Director - Professor N Jones). The Institute is dedicated to fundamental and
clinically orientated cancer research in many fields including radiobiology,
haematology, molecular biology, immunology, tumour chemotherapy and
cytogenetics.
A translational research facility is being built. There are
opportunities for clinical research in developmental RT, chemoradiotherapy and
biological therapies.
4)
Particulars of Contract
Any consultant who is unable for personal reasons to work full-time will be
eligible to be considered for the post. The job content will be discussed on a
personal basis and agreed with the Trust.
5)
Job Planning
All job plans will be reviewed annually. The annual review will examine all
aspects of the job plan and should be carried out jointly by the Clinical Director
and the postholder.
9
THE CHRISTIE NHS FOUNDATION TRUST
TERMS AND CONDITIONS OF EMPLOYMENT
The terms and conditions of the New Consultant Contract are applicable
Salary:
Will be on the New Consultant Contract payscale
Annual Leave:
0 - 7 years seniority
six weeks and 2 days per annum (pro rata for part time
employees)
7+ years seniority
six weeks and 4 days per annum (pro rata for part time
employees)
Bank Holiday:
8 public holidays
Resident:
The successful candidate will be required to
live within a reasonable travelling distance of
the Trust.
Arrangements to visit the hospital may be made direct with the: Department of Clinical Oncology
The Christie NHS Foundation Trust
Wilmslow Road
Withington
Manchester M20 4BX
Telephone number: 0161 446 8457
Fax: 0161 446 3084
Clinical Director: Dr J Logue
[email protected]
Tel: 0161 446 3407
Colorectal Enquiries: Dr M Saunders
[email protected]
0161 446 3357
Breast Enquiries: Dr B Magee
Brian.magee @christie.nhs.uk
0161 446 3404
10
APPENDIX 1
NAME
Clinical Oncology Consultant Staff
PERIPHERAL CLINIC SERVICE
Clinical Director
PRINCIPAL
INTEREST(S)
Dr J P Logue
Stockport
Genito-Urinary
Dr R A Cowan
Wigan
Lymphoma
Dr N J Slevin
Crewe
Head and Neck
Dr P A Burt
Crewe / MRI
Lung
Dr A Chittalia
Stockport
Breast
Lung
Dr A Choudhury
Oldham
Dr S E Davidson
Salford MDT
Gynaecology
Dr T Elliott
Bolton
Salford
Urology
Dr C Faivre-Finn
nil
Lung
Dr H R Gattamaneni Salford; Children’s Hospital
GU
CNS / Paeds
Dr M Harris
Tameside
Lung/Lymphoma
Dr L Barraclough
Macclesfield
Breast
Gynaecology
Prof T Illidge
Lymphoma
Dr L Bhatt
Tameside
Breast/ Oesophagus
Dr L Lee
Bury /NMGH
Head and neck
Lung
11
Dr JE Livsey
Oldham/St Marys
Gynaecology/urology
Dr J Loncaster
North Manchester
Breast
Dr B Magee
Salford
Breast
Dr V Misra
Oldham
Breast
Colorectal
Dr C McBain
Macclesfield
Salford
Colorectal
CNS
Dr J Coote
Oldham
Breast
Lung
Dr H Lander
Oldham
Breast
Lung
Dr M Saunders
Salford / Wythenshawe
Gastrointestinal
Dr H Sheikh
Salford /Macclesfield
Lung/oesophagus
Dr E Smith
North Manchester
Children’s Hospital
Lymphoma
Paediatric/Young Adult
Dr L Pemberton
Oldham
Lung
Dr A Sykes
Tameside
Head & Neck/Melanoma
Dr R S Welch
Bolton/Hope
Ovarian Cancer
Testicular cancer
Breast cancer
Dr J Wylie
Crewe/South Manchester
Genito-urinary
Soft Tissue
Sarcoma
Dr B Yap
Thyroid/Head &
Neck
Dr E Allan
(Part-time)
PDT for skin
Dr N Alam
Bolton / Salford / Stockport
Pennine Acute
Salford
Gastrointestinal
Genito-urinary
CNS Genito- Urinary
Dr A Tran
cancer
12
13
APPENDIX 2
PERSON SPECIFICATION - CONSULTANT IN CLINICAL ONCOLOGY
ATTAINMENTS
Education
ESSENTIAL
DESIRABLE
RCR Fellowship or
equivalent
Higher Degree
Training
Certificate of completed
specialist training or
equivalent (or within 6
months of CCT by
interview)
Job experience
Appropriate experience in
Breast and GI oncology
Demonstrates knowledge,
logic and efficiency
Integrity, management and
communication skills
including teaching
Developments in oncology
practice
GENERAL
INTELLIGENCE
SPECIAL APTITUDES
INTERESTS
DISPOSITION
Acceptability
Leadership
Self-reliance
Motivation
Research experience
Knowledge of continuing
NHS and Royal College
Reforms.
Is a team player prepared
to adapt to changing
circumstances.
Dynamic, decision-making
motivator.
Confident in ability, but
knowing own limitations.
Hardworking, enthusiastic
achiever.
Good attendance record.
Patient friendly.
Professional demeanour
Must be resilient and well
organised
14
15